• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Cleerly Secures $106M to Advance AI-Powered Cardiac Care

by Fred Pennic 12/05/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Cleerly, a pioneer in advanced cardiovascular imaging, has announced the successful closure of its Series C extension funding round, raising a total of $106M led by Insight Partners, with participation from Battery Ventures and existing investors. 

– The funding will enable Cleerly to expand its reach and make its AI-powered cardiac care solutions accessible to more patients as well as invest in research and clinical trials to further validate the effectiveness of its technology.

Expanding Access to Advanced Cardiac Care

Cleerly is committed to establishing a new standard of care for heart disease by leveraging its FDA-cleared, AI-driven technology. The company’s advanced non-invasive computed tomography (CT) imaging platform enables comprehensive phenotyping of coronary artery disease, providing clinicians with detailed insights to improve patient outcomes.

Cleerly’s AI-powered platform is transforming cardiac care by:

  • Improving diagnostic accuracy: Providing detailed and precise assessments of coronary artery disease.
  • Enabling early detection: Identifying individuals at risk of heart disease before symptoms develop.
  • Personalizing treatment plans: Guiding tailored treatment strategies based on individual patient needs.
  • Improving patient outcomes: Reducing the risk of heart attacks and other cardiovascular events.

Building on Recent Achievements

This funding comes on the heels of significant milestones for Cleerly, including:

  • Medicare coverage: Securing Medicare coverage for its advanced plaque analysis, expanding access to its technology for a wider patient population.
  • CPT Category I code: Obtaining a Category I Current Procedural Terminology (CPT) code for its advanced plaque analysis, facilitating reimbursement and wider adoption.

James K. Min, MD, Founder and CEO of Cleerly, expressed his enthusiasm about the financing, stating, “We are thrilled to receive this investment from Insight Partners, marking a significant milestone for Cleerly. This funding will allow us to expand our commercial reach, which is especially germane following our recent achievements in attaining Medicare coverage and a CPT Category I code for advanced plaque analysis. We are very excited to see our purpose-driven mission come to life, making advanced cardiac care accessible to more patients and working towards our goal of eliminating heart attacks.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, cardiac imaging

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |